All Episodes
Citeline Podcasts — 625 episodes · page 4 of 7
Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative
SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases
Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer
The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025
Podcast: Navigating the Future of Hepatology Clinical Trials
Innovation & Integrity: The Dual Path to Success for Device Makers
Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon
Scrip's Five Must-Know Things - 2 June 2025
Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation
FDA in Transition: How Regulatory Shifts Are Redefining Drug Development
Scrip's Five Must-Know Things - 26 May 2025
Drug Fix: US FDA’s Big Vaccine Policy Week
“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System
제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)
Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer
Scrip's Five Must-Know Things - 19 May 2025
China Biopharma Podcast - 14 May 2025 (Chinese language)
Scrip's Five Must-Know Things - 12 May 2025
Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns
Scrip's Five Must-Know Things - 7 May 2025
Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer
OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities
Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
Conference Catch-Up: BIO-Europe 2025
Highlights from AAN 2025
Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs
Scrip's Five Must-Know Things - 28 April 2025
Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval
Precision Medicine in Liver Treatment: The Ochre Bio Approach
Scrip's Five Must-Know Things - 21 April 2025
Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls
Scrip's Five Must-Know Things - 14 April 2025
미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)
Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls
Scrip's Five Must-Know Things - 7 April 2025
Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact
CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data
Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype
Scrip's Five Must-Know Things - 31 March 2025
Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA
Innovative Oncology, A Conversation with iOnctura
Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”
What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite
Scrip's Five Must-Know Things - 24 March 2025
Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches
Scrip's Five Must-Know Things - 17 March 2025
Drug Fix: Buyouts, Departures and Other US FDA Chaos
Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.
Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025
The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US
Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell
Scrip's Five Must-Know Things - 10 March 2025
Grove AI and Grace, An Agentic AI For Clinical Trial Engagement
Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?
【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)
트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)
The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley
Scrip's Five Must-Know Things - 3 March 2025
Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push
Scrip's Five Must-Know Things - 25 February 2025
Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley
Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry
Scrip's Five Must-Know Things - 18 February 2025
Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts
Podcast: JPM Tracked and Unpacked
Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)
Scrip's Five Must-Know Things - 10 February 2025
Getting Creative In Consumer Health, With All Creative’s Beverley Law
Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing
Scrip's Five Must-Know Things
Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration
Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI
Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings
Scrip's Five Must-Know Things - 27 January 2025
Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA
Fauna Bio: Gleaning Therapeutic Insights From Animals
Scrip's Five Must-Know Things - 20 January 2025
Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends
A “Game Changer” For The High-Risk MDS Patient Population
Scrip's Five Must-Know Things - 14 January 2025
Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On
2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)
Pre-JPM Biotech Dealmaking Roundtable
Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push
The Future of Immunotherapy
An Insight into NASH
올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024
Scrip's Five Must-Know Things - 23 December 2024
The Future Of eClinical Technology
The Generics Bulletin Podcast: Highlights Of 2024
Five Must-Know Things - 16 December 2024
The Role of Site Networks & Why They Matter
Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison
Scrip's Five Must-Know Things - 10 December 2024
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models
November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology
Treating Rare Diseases With tRNA
Conference Catch-Up: BIO-Europe 2024